Elm Genomics

Private

Cambridge-based oncology biotech building an AI-guided drug discovery platform for rare pediatric cancers. Runs 3 preclinical programs in solid tumor indications.

Founders Emma Thompson

CEO Emma Thompson

Company

Founded

2024

Headquarters

Cambridge, United States

Financials

Total Funding

$11M

Sectors

Artificial Intelligence Biotech

elmgenomics.com

Funding History

1 round

Seed Jul 8, 2026

$11M

Flagship Pioneering (Lead) Boldstart Ventures F-Prime Capital

Funding data is compiled from multiple independent sources including company announcements, press coverage, and regulatory filings. While we strive for accuracy, amounts and dates may reflect reported figures at time of announcement.